Prolonged response to first-generation tyrosine kinase inhibitor in a metastatic non-small cell lung cancer harbouring complex G719X and S768I mutations: A case report from Vietnam and literature review
K. H. Do, D. T. Le, et al.
Explore these studies to deepen your understanding
Adjacent work that informs or extends this paper's methodology and findings.
Association between pretreatment emotional distress and immune checkpoint inhibitor response in non-small-cell lung cancer
Y. Zeng, C. Hu, et al.
Efficacy and safety of nanoparticle albumin-bound paclitaxel monotherapy after immune checkpoint inhibitor administration for advanced non-small cell lung cancer: A multicenter Phase 2 clinical trial
T. Sonoda, Y. Umeda, et al.
Lymph Node Ratio Enhances Predictive Value for Treatment Outcomes in Patients with Non-Small Cell Lung Cancer Undergoing Surgery: A Retrospective Cohort Study
S. Wang, N. Mao, et al.
The Long Run towards Personalized Therapy in Non-Small-Cell Lung Cancer: Current State and Future Directions
C. Genova

